White matter disease: Roles of anti-MOG antibodies in demyelinating diseases

Nature Reviews Neurology

Volumn 7, Issue 5, 2011, Pages 248-249

  Olsson, Tomas ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; IMMUNOGLOBULIN; MYELIN BASIC PROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; PROTEIN ANTIBODY; STEROID;

ACUTE DISSEMINATED ENCEPHALOMYELITIS; ALLERGIC ENCEPHALOMYELITIS; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ARTICLE; B LYMPHOCYTE; BRAIN DISEASE; CYTOKINE PRODUCTION; DEMYELINATING DISEASE; DIFFERENTIAL DIAGNOSIS; HUMAN; IMMUNE RESPONSE; MULTIPLE SCLEROSIS; NEUROPATHOLOGY; NONHUMAN; PLASMAPHERESIS; PRIORITY JOURNAL; PROGNOSIS; T LYMPHOCYTE ACTIVATION; WHITE MATTER DISEASE;

AUTOANTIBODIES; AUTOANTIGENS; DEMYELINATING AUTOIMMUNE DISEASES, CNS; HUMANS; MYELIN-ASSOCIATED GLYCOPROTEIN;

EID: 79955863541     PISSN: 17594758     EISSN: 17594766     Source Type: Journal    
DOI: 10.1038/nrneurol.2011.45     Document Type: Article

References (10)

1. Lalive, P. et al. Highly reactive anti-myelin oligodendrocyte glycoprotein antibodies differentiate demyelinating diseases from viral encephalitis in children. Mult. Scler. 17, 297-302 (2011).
2. Di Pauli, F. et al. Temporal dynamics of anti- MOG antibodies in CNS demyelinating diseases. Clin. Immunol. 138, 247-254 (2011).
3. Selter, R. C. et al. Antibody responses to EBV and native MOG in pediatric inflammatory demyelinating CNS diseases. Neurology 74, 1711-1715 (2010).
4. Brilot, F. et al. Antibodies to native myelin oligodendrocyte glycoprotein in children with inflammatory demyelinating central nervous system disease. Ann. Neurol. 66, 833-842 (2009).
5. O'Connor, K. C. et al. Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein. Nat. Med. 13, 211-217 (2007).
6. McLaughlin, K. A. et al. Age-dependent B cell autoimmunity to a myelin surface antigen in pediatric multiple sclerosis. J. Immunol. 183, 4067-4076 (2009).
7. Brehm, U., Piddlesden, S. J., Gardinier, M. V. & Linington, C. Epitope specificity of demyelinating monoclonal autoantibodies directed against the human myelin oligodendrocyte glycoprotein (MOG). J. Neuroimmunol. 97, 9-15 (1999). (Pubitemid 29301408)
8. Weissert, R. et al. MHC haplotype-dependent regulation of MOG-induced EAE in rats. J. Clin. Invest. 102, 1265-1273 (1998). (Pubitemid 28436287)
9. Wallström, E. et al. Increased reactivity to myelin oligodendrocyte glycoprotein peptides and epitope mapping in HLA DR2(15)+ multiple sclerosis. Eur. J. Immunol. 28, 3329-3335 (1998). (Pubitemid 28470279)
10. Hauser, S. L. et al. B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. N. Engl. J. Med. 358, 676-688 (2008). (Pubitemid 351240747)